Biologics & Injectables Index
Convert Unblinded Payer Perceptions into Insights
Track current and emerging trends about biologics and injectables with perspectives from payers, HCPs, office managers, representing 75% of Commercial and Medicare lives. Capture unblinded payer perceptions to drive insightful action.
Learn More
Examine
Examine payer reactions to relevant topics affecting healthcare each quarter.
Assess
Assess high level payer management techniques, site of care dynamics, and administration burden via Access Management Topics.
Review
Review a deep dive of specific therapeutic areas, including analysis of disruptive events and payer perceptions of new or emerging therapies.
Understand
Understand perspectives from key payer stakeholders representing 75% of Commercial and Medicare lives.
How We Help
MMIT's Biologics and Injectables Index gathers insights through field research with its industry-leading panel of pharmacy decision-makers at health plans, PBMs, providers and integrated delivery systems. 100% of panelists are either active P&T participants or control access for pharmaceuticals for their organizations, giving you unparalleled visibility into these entities.
Understand
Understand which biologic and injectable agents are more commonly prescribed by HCPs and their familiarity with upcoming launches.
Uncover
Uncover patient concerns that are most commonly discussed with their physician when looking for new starts on biologic and injectable therapies or when being forced to switch.
Review
Review Practice Manager and HCP perception of administration burden for each brand.
Observe
Observe anticipated coverage changes within a payer organization over time for its Commercial and Medicare lines of business.
Discover More About
Biologics & Injectables
Index
Improve decision making with a forward-looking analysis into access management topics and therapeutic area management, sourced directly from payers, HCPs, and practice managers representing 75% of Commercial & Medicare lives.
Solutions to Support Your Strategy
Oncology Index
Leverage the MMIT Oncology Index to synthesize insights into an analysis of payer trends, oncology management, and disruptive market events.
Message Monitor
Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.
Rapid Response
Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.
P&T Perspectives
P&T Perspectives provides qualitative and tangible feedback through a simulated P&T session that informs your brand’s strategy and helps you determine how your product—or your competitor’s product—will fare in a real P&T Committee review.